• slider-dummy-1.jpg
  • image3.jpg
  • image4.jpg

Sandoz is a world leader in generic pharmaceuticals, finding innovative ways to making medicines affordable and accessible to more than 90 percent of the world’s population.

Learn more about our company
Visions and Values


Sandoz launches innovative respiratory inhaler AirFluSal® Forspiro® in the UK

November 20, 2015

Sandoz, a Novartis company, today announces the launch of AirFluSal® Forspiro®, an innovative inhaler for patients with asthma and/or chronic obstructive pulmonary disease (COPD), in the United Kingdom.


Our people are our greatest resource. We are always looking for new colleagues to share in our commitment to make the world a healthier place.

Learn more about careers at Sandoz

Watch our videos to discover more about the world of Sandoz and the generics market.

Visit our video gallery to watch the latest episode



We have collected the most important and frequently asked questions about our business.

Visit our frequently asked questions page